Figure 5.

Influence of iloprost infusion and its combination with AH 6809 and BIM on U46619-elicited pulmonary hypertension. Pulmonary artery pressure (PAP) is given (mean ± SEM of 4 independent experiments each, SEM bars are missing when enclosed by the symbol). (A) The prostaglandin E₁ receptor antagonist AH 6809 alone or in combination with iloprost (pre-applied followed by an iloprost infusion). (B) The PKC inhibitor BIM alone or in combination with iloprost (pre-applied followed by an iloprost infusion).